Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$209.01 - $232.56 $20,273 - $22,558
97 Added 5.94%
1,729 $377,000
Q4 2023

Feb 07, 2024

SELL
$197.69 - $227.29 $3,756 - $4,318
-19 Reduced 1.15%
1,632 $370,000
Q3 2023

Nov 07, 2023

BUY
$201.05 - $221.7 $22,316 - $24,608
111 Added 7.21%
1,651 $331,000
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $7,205 - $8,205
-34 Reduced 2.16%
1,540 $371,000
Q1 2023

Apr 28, 2023

SELL
$213.32 - $257.83 $8,319 - $10,055
-39 Reduced 2.42%
1,574 $361,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $611 - $746
3 Added 0.19%
1,613 $379,000
Q3 2022

Nov 01, 2022

BUY
$204.81 - $262.19 $22,938 - $29,365
112 Added 7.48%
1,610 $330,000
Q2 2022

Aug 02, 2022

SELL
$213.86 - $277.87 $63,944 - $83,083
-299 Reduced 16.64%
1,498 $351,000
Q1 2022

Apr 27, 2022

BUY
$259.82 - $298.18 $43,389 - $49,796
167 Added 10.25%
1,797 $473,000
Q4 2021

Jan 24, 2022

BUY
$271.6 - $314.21 $93,973 - $108,716
346 Added 26.95%
1,630 $512,000
Q3 2021

Oct 21, 2021

BUY
$274.82 - $308.34 $73,376 - $82,326
267 Added 26.25%
1,284 $361,000
Q2 2021

Jul 29, 2021

SELL
$251.87 - $278.14 $61,204 - $67,588
-243 Reduced 19.29%
1,017 $284,000
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $55,932 - $69,623
273 Added 27.66%
1,260 $324,000
Q4 2020

Jan 22, 2021

SELL
$186.91 - $214.42 $120,930 - $138,729
-647 Reduced 39.6%
987 $200,000
Q3 2020

Oct 14, 2020

BUY
$167.03 - $201.3 $272,927 - $328,924
1,634 New
1,634 $308,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.